News-Details

Why do capital-intensive medical products often fail in the German healthcare market?

Market access for capital-intensive technologies is significantly more difficult than, for example, for implants or consumable supplies.

The access to the German healthcare market is complex, strictly regulated, and difficult to plan. This is particularly true for capital goods. 

Market access for capital-intensive medical devices in Germany is not based solely on clinical or technological added value, but primarily on clearly defined systemic and economic rules. Value arguments are not enough.

Success comes when products and strategies are consistently aligned with these specific conditions. Sustainable market entry requires a deep understanding of the system’s logic and the decision-making mechanisms on hospitals’ side.

You are looking for a realistic and economically viable market access for your capital-intensive medical device?

Let us discuss your initial situation in a complementary consultation.

Author: Healthcare Heads GmbH

Phone: +49 431 800 1470

E-Mail: info@healthcareheads.com